Nurix Therapeutics, Inc. has grown revenue −16% a year over three years and 10.0% a year over five. Revenue growth, 3-year annual rate: −16% (Biotechnology median +21%). Revenue growth, 5-year rate: +10.0%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

NRIXNurix Therapeutics, Inc.

HealthcareUSD

$26.68

$8.2452 weeks$27.79

Is it growing?

Is NRIX growing?

Nurix Therapeutics, Inc. has grown revenue −16% a year over three years and 10.0% a year over five.

−16%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +10.0%
Revenue growth, 5-year rate · −16% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›